Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1ALN-CC5----4件: 11, 62, 66, 109 💬
2ALXN1210----7件: 2, 11, 13, 50, 62, 66, 109 💬
3ANTI-C5 antibody----4件: 11, 14, 62, 109 💬
4C5 INH MAB, SKY59, RO/CH7092230----2件: 62, 109 💬
5CCX168----6件: 43, 44, 49, 66, 109, 222 💬
6Cemdisiran1件: Cemdisiran---4件: 11, 62, 66, 109 💬
7Coversin1件: Nomacopan1件: Nomacopan 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬2件: 62, 109 💬
8Crovalimab1件: Crovalimab1件: Crovalimab 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬2件: 62, 109 💬
9Eculizumab1件: Eculizumab1件: Eculizumab 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬8件: 11, 13, 14, 61, 62, 109, 221, 222 💬
10FC- and CDR-modified humanised monoclonal antibody against C5----3件: 11, 62, 109 💬
11Iptacopan1件: Iptacopan2件: Iptacopan ,
Iptacopan hydrochloride 💬 		1件: CFB 💬 3件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬6件: 11, 61, 62, 66, 109, 222 💬
12Iptacopan hydrochloride1件: Iptacopan2件: Iptacopan ,
Iptacopan hydrochloride 💬 		1件: CFB 💬 3件: Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬4件: 61, 66, 109, 222 💬
13Iptcaopan 200 MG----1件: 109 💬
14LNP023----5件: 61, 62, 66, 109, 222 💬
15NM8074----4件: 50, 62, 66, 109 💬
16OMS00620646, OMS620646, MASP-2 antibody----1件: 109 💬
17OMS721----4件: 64, 66, 109, 222 💬
18OMS721 100 MG/ML injection solution, OMS00620646, OMS620646, MASP-2 antibody----2件: 64, 109 💬
19OMS721 185 MG/ML injection solution, OMS00620646, OMS620646, MASP-2 antibody----2件: 64, 109 💬
20OMS721 drug product 185 MG/ML----1件: 109 💬
21Ravulizumab1件: Ravulizumab1件: Ravulizumab 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬7件: 2, 11, 13, 50, 62, 66, 109 💬
22RO7112689/F03-01----2件: 62, 109 💬
23RO7112689/F03-10----2件: 62, 109 💬
24RVA576----3件: 62, 109, 162 💬
25Solaris----2件: 62, 109 💬
26Soliris1件: Eculizumab1件: Eculizumab 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬6件: 11, 13, 14, 62, 109, 222 💬
27Soliris 300 MG concentrado para solucióN para perfusióN1件: Eculizumab1件: Eculizumab 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 109 💬
28Soliris 300 MG solution à diluer pour perfusion1件: Eculizumab1件: Eculizumab 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬1件: 109 💬
29Ultomiris1件: Ravulizumab1件: Ravulizumab 💬 1件: C5 💬 11件: Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬7件: 2, 11, 13, 50, 62, 66, 109 💬